Danaher 2011 Annual Report Download - page 10

Table of Contents
Life Sciences
We established our life sciences business in 2005 through the acquisition of Leica Microsystems, and have expanded the business through numerous
subsequent acquisitions, including the acquisitions of AB Sciex and Molecular Devices in 2010 and Beckman Coulter, Inc. in 2011. The life sciences
business consists of the following businesses.
Our microscopy business is a leading global provider of professional microscopes designed to manipulate, preserve and capture images of, and enhance the
user’s visualization of, microscopic structures. Our microscopy products include:
• laser scanning (confocal) microscopes;
• compound microscopes and related equipment;
• surgical and other stereo microscopes; and
• specimen preparation products for electron microscopy; and
• digital image capture and manipulation equipment.
Typical users of these products include research, medical and surgical professionals operating in research and pathology laboratories, academic settings and
surgical theaters.
We also offer workflow instruments and consumables that help researchers analyze genomic, protein and cellular information. Key product areas include
sample preparation equipment such as centrifugation and capillary electrophoresis instrumentation and consumables; liquid handling automation instruments
and associated consumables; flow cytometry instrumentation and associated antibodies and reagents; and particle characterization instrumentation. The
business also offers genome profiling services. Researchers use the business’ products to study biological function in the pursuit of basic research, therapeutic
and diagnostic development. Typical users of these products include pharmaceutical and biotechnology companies, universities, medical schools and research
institutions and in some cases industrial manufacturers.
Our mass spectrometry business is a leading global provider of high-end mass spectrometers. Mass spectrometry is a technique for identifying, analyzing and
quantifying elements, chemical compounds and biological molecules, individually or in complex mixtures. Our products utilize various combinations of
quadrupole, time-of-flight and ion trap technologies, and are typically used in conjunction with a third party liquid chromatography instrument. Our mass
spectrometer systems are used in numerous applications such as drug discovery and clinical development of therapeutics as well as in basic research, clinical
testing, food and beverage quality testing and environmental testing. To support our installations around the world, we provide implementation, validation,
training, maintenance and support from our global services network. Typical users of our mass spectrometry products include molecular biologists,
bioanalytical chemists, toxicologists, and forensic scientists as well as quality assurance and quality control technicians. We also provide high-performance
bioanalytical measurement systems, including microplate readers, automated cellular screening products and associated reagents, and imaging software.
Typical users of these products include biologists and chemists engaged in research and drug discovery, who use these products to determine electrical or
chemical activity in cell samples.
Customers in the life sciences industry select products based on a number of factors, including product quality and reliability, innovation (particularly
productivity and sensitivity improvements), the product’s capacity to enhance productivity, product performance and ergonomics, access to a highly qualified
service and support network and the other factors described under “—Competition.” Our life sciences business generally markets its products under the
LEICA MICROSYSTEMS, BECKMAN COULTER, AB SCIEX and MOLECULAR DEVICES brands. Manufacturing facilities are located in Europe,
Australia, Asia and North America. The businesses sell to customers primarily through direct sales personnel and to a lesser extent through independent
distributors.

Our Dental segment is a leading worldwide provider of a broad range of consumables, equipment and services for the dental market, which encompasses the
diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. The market we serve encompasses the whole working
environment of an oral health professional and we are dedicated to driving technological innovations that help dental professionals improve clinical outcomes
and enhance productivity. Sales for this segment in 2011 by geographic destination were: North America, 49%; Europe, 34%; Asia/Australia, 10%; and other
regions, 7%.
8
Source: DANAHER CORP /DE/, 10-K, February 24, 2012 Powered by Morningstar® Document Research℠
The information contained herein may not be copied, adapted or distributed and is not warranted to be accurate, complete or timely. The user assumes all risks for any damages or losses arising from any use of this information,
except to the extent such damages or losses cannot be limited or excluded by applicable law. Past financial performance is no guarantee of future results.